Table 2.
Risk of bias for included trials.
| Study | Sequence generation | Allocation concealment | Blinding | Incomplete outcome data | Selective outcome reporting | Other sources of bias |
|---|---|---|---|---|---|---|
| Zhong 2014 [26] | (−) | 0 | 0 | (−) | (+) | (−) |
| Zhang 2008 [25] | (−) | 0 | 0 | (−) | (−) | (−) |
| Zhang 2016 [24] | 0 | 0 | 0 | (−) | (−) | (−) |
| Ruan 2014 [18] | (−) | 0 | 0 | (−) | (−) | (−) |
| Zhong 2011 [23] | (−) | 0 | 0 | (−) | (+) | (−) |
| Xiang 2011 [21] | 0 | 0 | 0 | (−) | (−) | (−) |
| Wang 2010 [19] | (−) | 0 | 0 | (−) | (−) | (−) |
| Zhou 2005 [20] | 0 | 0 | 0 | (−) | (−) | 0 |
| Xu 2014 [22] | (−) | 0 | 0 | (−) | (−) | 0 |
| Liu 2010 [17] | 0 | 0 | 0 | (−) | (−) | (−) |
| Liang 2014 [16] | (−) | 0 | 0 | (−) | (−) | (−) |
| Hao 2014 [15] | (−) | 0 | 0 | (−) | (−) | (−) |
| Gao 2015 [14] | (−) | 0 | 0 | (−) | (−) | (−) |
| Li 2015 [27] | 0 | 0 | 0 | (−) | (−) | 0 |
| Ya 2010 [28] | 0 | 0 | 0 | (−) | (−) | (−) |
| Zhang 2016 [29] | (−) | 0 | 0 | (−) | (−) | (−) |
Note. Low risk of bias: (−); unclear: 0; high risk of bias: (+).